<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>be13ff47-e8f6-44a9-b864-34821f13b71f</id>
  <name>Graft vs Host Disease Adult Smart Set_Ambulatory</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ﻩ Technical Traceability</key>
        <value>{~AHSID~be13ff47-e8f6-44a9-b864-34821f13b71f~NAME~Graft vs Host Disease Adult Smart Set_Ambulatory}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;Smart Set Keywords: Cancer, GVHD, BMT, Skin, Liver, Gut, GI, HCT, cellular therapy&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Refer to the&amp;nbsp;&lt;u&gt;&lt;strong&gt;Alberta Bone Marrow and Blood Cell Transplant Program: Standard Practice Manual&amp;nbsp;&lt;/strong&gt;&lt;/u&gt;for guidance (URL: https://ahsweb.ca/HEE/AB_Bone_Marrow_Blood_Cell_Transplant_Program_Manual)&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;General&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Decision Support - Acute&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;u&gt;&lt;strong&gt;Acute GVHD&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Stage&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Skin&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Liver&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Gut&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No rash&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Total bilirubin &amp;lt; 34 umol/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No diarrhea&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;1&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Maculopapular rash &amp;lt;25% body surface area&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Total bilirubin 34 to 50 umol/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Diarrhea 500 – 1000 mL/day or nausea with positive gastric biopsy&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;2&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Maculopapular rash 25-50% body surface area&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Total bilirubin 51 to 100 umol/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Diarrhea 1000 – 1500 mL/day&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;3&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Maculopapular rash &amp;gt;50% body surface area&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Total bilirubin 101 to 250 umol/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Diarrhea 1500 – 2000 mL/day&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;4&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Generalized exfoliative, ulcerative or bullous dermatitis&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Total bilirubin &amp;gt; 250 umol/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Diarrhea &amp;gt;2000 mL/day or severe abdominal pain or ileus&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td colspan=&quot;5&quot;&gt;&lt;p&gt;Stage&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Grade&lt;/p&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&lt;p&gt;Skin&lt;/p&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&lt;p&gt;Liver&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Gut&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;And&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;And&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;I&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;1-2&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;And&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;And&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;II&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;3&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Or&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;1&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Or&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;1&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;III&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2-3&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Or&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;2-4&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;IV&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Or&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;4&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;General&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Decision Support - Chronic&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;&lt;u&gt;&lt;strong&gt;Chronic GVHD&lt;/strong&gt;&lt;/u&gt;&lt;/p&gt;&lt;table border=&quot;1&quot; cellspacing=&quot;0&quot; cellpadding=&quot;0&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Organ Scores&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Score 0&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Score 1&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Score 2&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Score 3&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;SKIN&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&amp;lt;19% BSA with disease signs but NO sclerotic features&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;19-50% BSA OR involvement with superficial sclerotic features “not hidebound” (able to pinch)&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;&amp;gt;50% BSA OR deep sclerotic features “hidebound” (not able to pinch) OR impaired mobility, ulceration, or severe pruritis&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;MOUTH&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Mild symptoms with disease signs but not limiting oral intake significantly&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Moderate symptoms with disease signs with partial limitation of oral intake&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Severe symptoms with disease signs on examination with major limitation of oral intake&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;EYES&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Mild dry eye symptoms not affecting ADL (requiring eyedrops &amp;lt; 3 times daily) OR asymptomatic signs of keratoconjunctivitis sicca&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Moderate dry eye symptoms partially affecting ADL (requiring drops &amp;gt;3 times daily or puntal plugs) WITHOUT vision impairment&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Severe dry eye symptoms significantly affecting ADL (special eyewear to relieve pain) OR unable to work because of ocular symptoms) OR loss of vision caused by keratoconjunctivitis sicca&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;GI TRACT&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Symptoms such as dysphagia, anorexia, nausea, vomiting, abdominal pain or diarrhea without significant weight loss (&amp;lt;5%)&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Symptoms associated with mild to moderate weight loss (5-15%)&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Symptoms associated with significant weight loss &amp;gt;15%, requires nutritional supplement for most calorie needs OR esophageal dilation&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;LIVER&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Normal LFT&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Bilirubin (total) normal&lt;/p&gt;&lt;p&gt;ALT 180-300 U/L&lt;/p&gt;&lt;p&gt;ALP ≥429 U/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Bilirubin 24-72 umol/L&lt;/p&gt;&lt;p&gt;ALT &amp;gt;300 U/L&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Bilirubin &amp;gt;72 umol/L&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;LUNGS&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;p&gt;FEV1 &amp;gt;80%&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Mild symptoms (shortness of breath after climbing 1 flight of steps), or&lt;/p&gt;&lt;p&gt;FEV1 60-79%&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Moderate symptoms (shortness of breath after walking on flat ground), or&lt;/p&gt;&lt;p&gt;FEV1 40-59%&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Severe symptoms (shortness of breath at rest requiring O2), or&lt;/p&gt;&lt;p&gt;FEV1 &amp;lt;39%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;JOINTS &amp;amp; FASCIA&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Mild tightness of arms or legs, normal or mild decreased range of motion AND not affecting ADL&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Tightness of arms or legs OR joint contractures, erythema thought due to fascitis, moderate decreased range of motion AND mild to moderate limitation of ADL&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Contractures WITH significant decrease of range of motion AND significant limitation of ADL (unable to tie shoes, button shirt, dress self)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;&lt;strong&gt;GENITAL TRACT*&lt;/strong&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;No symptoms/signs&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Mild signs*&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Moderate signs*&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;Severe signs*&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&lt;em&gt;*Genital signs:&lt;/em&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Female genitalia:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;1) Mild (any of the following); erythema on vulvar mucosal surfaces, vulvar lichen-planus or vulvar lichen-sclerosis.&lt;/p&gt;&lt;p&gt;2) Moderate (any of the following); erosive inflammatory changes of the vulvar mucosa, fissures in vulvar folds&lt;/p&gt;&lt;p&gt;3) Severe (any of the following); labial fusion, clitoral hood agglutination, fibrinous vaginal adhesions, circumferential fibrous vaginal banding, vaginal shortening, synechia, dense sclerotic changes, and complete vaginal stenosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Male genitalia:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;1) Mild: lichen planus-like feature;&lt;/p&gt;&lt;p&gt;2) Moderate: lichen sclerosus-like feature or moderate erythema;&lt;/p&gt;&lt;p&gt;3) Severe: phimosis or urethral/meatal scarring.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Global Score:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Mild cGVHD:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;≤2 organs involved with max organ score 1, plus lung score 0&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Moderate cGVHD:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;≥3 organs involved with max score 1, or&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;≥1 organ (not lung) with a score of 2, or&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;Lung score 1&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Severe cGVHD:&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;≥1 organ with a score of 3, or&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;•&amp;nbsp;&lt;strong&gt;Lung score 2 or 3&lt;/strong&gt;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;First Line Treatment of Acute GVHD is corticosteriods.&lt;/p&gt;&lt;p&gt;Second Line Treatment of Acute GVHD (Steroid-Refractory) is Ruxolitnib&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Please refer to the ABMTP standard practice manual for dosing direction. See link at beginning of order set.&amp;nbsp;&lt;br&gt;Budesonide is currently non-formulary for GVHD, it is available off the facility list as needed. Suggested initial dosing is 3 mg, oral, 2 times per day.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;predniSONE Tablet; 0.5 mg/kg/dose, oral, 2 times per day, with breakfast and supper&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; Take *** tablets (*** mg total) by mouth two (2) times per day (with breakfast and supper) for *** days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;predniSONE Oral liquid 5 mg/mL; 0.5 mg/kg/dose, oral, 2 times per day, with breakfast and supper&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; Take *** mL&amp;nbsp;(*** mg total) by mouth two (2) times per day (with breakfast and supper) for *** days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;budesonide, long acting Capsule; 3 mg, oral, 2 times per day&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; Take 1 capsule (3 mg total) by mouth two (2) times per day&amp;nbsp;for *** days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;beclomethasone 1 mg_mL Liquid Oral; 2 mg, oral, 4 times per day&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp; Take 2 mL (2&amp;nbsp;mg total) by mouth four (4) times per day&amp;nbsp;for *** days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;Request NO default dose for medications in this section&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;cycloSPORINE Oral liquid 100 mg/mL; ***, oral, 2 times per day for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take by mouth *** (***) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;cycloSPORINE Capsule; *** mg, oral, every 12 hours, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take ***&amp;nbsp;capsule by mouth every 12&amp;nbsp;(12) hours&amp;nbsp;for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tacrolimus 1 mg_mL Liquid Oral; *** mg, oral, 2 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take *** mL (*** mg total) by mouth two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tacrolimus Capsule; *** mg, oral, 2 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take *** capsule&amp;nbsp;(0.5 mg total) by mouth two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;sirolimus Oral liquid 1 mg /mL; *** mg, oral, daily, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take *** mLs (*** mg total) by mouth one (1) time per day (in the morning) for 30 days.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;sirolimus Tablet; *** mg, oral, daily, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take *** tablets&amp;nbsp;(*** mg total) by mouth one (1) time per day (in the morning) for 30 days. Do not crush, chew, or split.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;mycophenolate mofetil Tablet; *** mg, oral, 2 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take by mouth two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;mycophenolate mofetil Capsule; *** mg, oral, 2 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take by mouth two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Immunosuppressive Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;mycophenolate mofetil Oral liquid 200 mg/mL; *** mg, oral, 2 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: Take by mouth two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Topical Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;betamethasone valerate Cream 0.1%; topical, 3 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Patient Sig: Apply topically two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Topical Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;hydrocortisone acetate Cream 1%; topical, 3 times per day, for 30 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Patient Sig: Apply topically two (2) times per day for 30 days&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Prescription Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ophthalmic Drops&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;prednisoLONE acetate Eye drop 1%; *** drops, *** eye(s), 4 times per day, for 10 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;&amp;nbsp;Patient Sig: 1 drop four (4) times per day for 10 days.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Graft vs Host Disease Adult Ambulatory Smart Set">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="General">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Decision Support - Acute"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Decision Support - Chronic"/>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Prescription Medications">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Decision Support"/>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Corticosteroids">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ed859f75-e62d-4e33-91d8-c3c591f89101" concept_name="PHARM predniSONE Tablet Order" max="1" path="/items" name="predniSONE Tablet; 0.5 mg/kg/dose, oral, 2 times per day, with breakfast and supper"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a6f18540-d8c3-4299-9fc6-6ad053a2a33e" concept_name="PHARM predniSONE Oral liquid 5 mg/mL Order" max="1" path="/items" name="predniSONE Oral liquid 5 mg/mL; 0.5 mg/kg/dose, oral, 2 times per day, with breakfast and supper"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ee5595b2-3b41-4372-86e9-d04a319aab4d" concept_name="PHARM budesonide, long acting Capsule Order" max="1" path="/items" name="budesonide, long acting Capsule; 3 mg, oral, 2 times per day"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="809886da-c326-49f5-8fa9-9aaaa6cbc5d5" concept_name="PHARM beclomethasone 1 mg_mL Liquid Oral Order" max="1" path="/items" name="beclomethasone 1 mg_mL Liquid Oral; 2 mg, oral, 4 times per day"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Second Line Treatment">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1b4965e4-58a0-4491-b876-372a730dff4b" concept_name="PHARM ruxolitinib Tablet Order" max="1" path="/items" name="ruxolitinib Tablet; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Immunosuppressive Agents">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f1133e85-8cd4-4835-8a35-21a337082f0a" concept_name="PHARM cycloSPORINE Oral liquid 100 mg/mL Order" max="1" path="/items" name="cycloSPORINE Oral liquid 100 mg/mL; ***, oral, 2 times per day for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2eab22a1-e33f-4079-b140-ee8ddbd5aee0" concept_name="PHARM cycloSPORINE Capsule Order" max="1" path="/items" name="cycloSPORINE Capsule; *** mg, oral, every 12 hours, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2c490bb3-caa7-4461-add4-7c03b62603d2" concept_name="PHARM tacrolimus 1 mg_mL Liquid Oral Order" max="1" path="/items" name="tacrolimus 1 mg_mL Liquid Oral; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c2d057f7-d848-496d-9538-d684500d8e8e" concept_name="PHARM tacrolimus Capsule Order" max="1" path="/items" name="tacrolimus Capsule; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="512eca5e-297f-452e-8a9d-1f25d43af785" concept_name="PHARM sirolimus Oral liquid 1 mg /mL Order" max="1" path="/items" name="sirolimus Oral liquid 1 mg /mL; *** mg, oral, daily, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7c309226-3c69-499b-a245-6518accb4751" concept_name="PHARM sirolimus Tablet Order" max="1" path="/items" name="sirolimus Tablet; *** mg, oral, daily, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c739192a-f050-437c-b146-3262c9ed1d24" concept_name="PHARM mycophenolate mofetil Tablet Order" max="1" path="/items" name="mycophenolate mofetil Tablet; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="293500c5-1dd7-4032-a453-be51e11b142c" concept_name="PHARM mycophenolate mofetil Capsule Order" max="1" path="/items" name="mycophenolate mofetil Capsule; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="be739051-e95c-430b-a2ef-d453f3dee564" concept_name="PHARM mycophenolate mofetil Oral liquid 200 mg/mL Order" max="1" path="/items" name="mycophenolate mofetil Oral liquid 200 mg/mL; *** mg, oral, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Topical Agents">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="68478d78-bb7b-431c-8470-45234d1e6f77" concept_name="PHARM betamethasone valerate Cream 0.1% Order" max="1" path="/items" name="betamethasone valerate Cream 0.1%; topical, 3 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="32f6be99-5710-4516-bbe7-fdd2016c92e2" concept_name="PHARM hydrocortisone acetate Cream 1% Order" max="1" path="/items" name="hydrocortisone acetate Cream 1%; topical, 3 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f1133e85-8cd4-4835-8a35-21a337082f0a" concept_name="PHARM cycloSPORINE Oral liquid 100 mg/mL Order" max="1" path="/items" name="cycloSPORINE Oral liquid 100 mg/mL; 5 mL, swish and spit, 4 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="9cc7f7fc-f36b-44b3-a569-ba28fe6de1d7" concept_name="PHARM betamethasone sodium phosphate Enema 5 mg/100 mL Order" max="1" path="/items" name="betamethasone sodium phosphate Enema 5 mg/100 mL; 10 mL, swish and spit, 4 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7b08a4fd-5204-43d6-95c4-cd576668a497" concept_name="PHARM tacrolimus Oint 0.03% Order" max="1" path="/items" name="tacrolimus Oint 0.03%; topical, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a99234a8-8aa5-4d09-ac99-1b3f546099fd" concept_name="PHARM tacrolimus Oint 0.1% Order" max="1" path="/items" name="tacrolimus Oint 0.1%; topical, 2 times per day, for 30 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ophthalmic Drops">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ecba7cad-75a6-46d7-b0f9-abb2c0ef4998" concept_name="PHARM prednisoLONE acetate Eye drop 1% Order" max="1" path="/items" name="prednisoLONE acetate Eye drop 1%; *** drops, *** eye(s), 4 times per day, for 10 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa80ca89-b938-4053-b4ab-6eaf57409b6f" concept_name="PLACEHOLDER Order Item" max="1" path="/items" name="PLACEHOLDER; cyclosporine 0.05% eye drops; *** drops, *** eye(s), every 12 hours, for 10 days"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
      </Item>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
</template>